COMPOSITIONS ET PROCÉDÉS D'INHIBITION D'EXPRESSION DU GÈNE ALAS1
- 专利权人:
- Alnylam Pharmaceuticals, Inc.;Icahn School of Medicine at Mount Sinai
- 发明人:
- 申请号:
- EP17175148.0
- 公开号:
- EP3284824A1
- 申请日:
- 2013.04.10
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
- 来源网站:
- 中国工程科技知识中心